Make money doing the work you believe in
There hasn't previously been a treatment vs pancreatic cancer this successful. Striking improved (a doubling) survival results
published today with daraxonrasib, which also became available via an FDA approved early access program and began shipping to physicians this week
May 31
at
3:22 PM